tirzepatide vs semaglutide clinical comparison 2026: 22% vs 15% Weight Loss Guide GLP-1 Medications for Weight Loss:

The shortterm randomized trial provides the strongest currently available evidence and supports the conclusion that tirzepatide can reduce body weight over 12 weeks in adults with T1D and obesity [9]

Diabetes Ther 16 , 977991 (2025)

Source: SURMOUNT-1 trial data (Jastreboff et al., NEJM 2022) Tip: If side effects are intolerable at a new dose, your prescriber may extend the current level for an additional 4 weeks rather than escalating

Recently, there have been reports of women who have previously struggled with infertility who were able to conceive after starting treatment with a glucagon-like peptide-1 receptor agonist (GLP-1) medication, such as semaglutide or tirzepatide

Mandy Crow